title: Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations.
authors.affiliation: Medical Oncology Unit, Thoraco-Pulmonary Department, National Cancer Institute, Napoli, Italy. alessandromorabito1@virgilio.it
authors.forename: Alessandro
authors.initials: A
authors.lastname: Morabito
authors.forename: Raffaele
authors.initials: R
authors.lastname: Costanzo
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Rachiglio
authors.forename: Raffaella
authors.initials: R
authors.lastname: Pasquale
authors.forename: Claudia
authors.initials: C
authors.lastname: Sandomenico
authors.forename: Renato
authors.initials: R
authors.lastname: Franco
authors.forename: Agnese
authors.initials: A
authors.lastname: Montanino
authors.forename: Elisabetta
authors.initials: E
authors.lastname: De Lutio
authors.forename: Gaetano
authors.initials: G
authors.lastname: Rocco
authors.forename: Nicola
authors.initials: N
authors.lastname: Normanno
mesh_terms: D000368:Aged; D018287:Carcinoma, Large Cell / Q000188:drug therapy / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D009154:Mutation / Q000235:genetics*; D009362:Neoplasm Metastasis; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; C512478:EGFR protein, human; D066246:ErbB Receptors; D000077156:Gefitinib